Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACER: Trimetazidine to Enhance Clopidogrel Response
NCT03603249Phase 2Completed
- Sponsor
- The University of the West Indies
- Start
- Jul 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trimetazidine in platelet dysfunction (PFD), sponsored by The University of the West Indies. Started Jul 2018; status: completed.
02
Drugs
trimetazidine
03
Conditions
platelet dysfunction (PFD)
Beyond the preview
Go deeper on NCT03603249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03603249.